Targeted Regulatory T Cells to Treat SLE

Ooi, Joshua (Primary Chief Investigator (PCI))
Faridi, Pouya (Chief Investigator (CI))
Morand, Eric (Chief Investigator (CI))

Project: Research

Status	Active
Effective start/end date	1/09/22 → 31/08/25

Funding

United States Department of Defense (DOD): A$1,075,902.10
US Army Medical Research Acquisition Activity

1 Article

Smith-specific regulatory T cells halt the progression of lupus nephritis
Eggenhuizen, P. J., Cheong, R. M. Y., Lo, C., Chang, J., Ng, B. H., Ting, Y. T., Monk, J. A., Loh, K. L., Broury, A., Tay, E. S. V., Shen, C., Zhong, Y., Lim, S., Chung, J. X., Kandane-Rathnayake, R., Koelmeyer, R., Hoi, A., Chaudhry, A., Manzanillo, P., Snelgrove, S. L., & 2 othersMorand, E. F. & Ooi, J. D., 6 Feb 2024, In: Nature Communications. 15, 1, 14 p., 899.
Research output: Contribution to journal › Article › Research › peer-review

Open Access

8 Citations (Scopus)

Animal Research Platform (MARP)
Christine Findlay (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility
FlowCore
Andrew Fryga (Manager)
Faculty of Medicine Nursing and Health Sciences Research Platforms
Facility/equipment: Facility